Cargando…
Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients
Non-small cell lung cancer (NSCLC) is the main reason of cancer linked mortality and around 80% of cases diagnosed in advanced stage. Therefore current study designed to evaluate the deregulation of miRNA-194 and miRNA-192 in different body fluid of Non small cell lung cancer participants. Present s...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938118/ https://www.ncbi.nlm.nih.gov/pubmed/33732041 http://dx.doi.org/10.1016/j.sjbs.2021.01.013 |
_version_ | 1783661537370570752 |
---|---|
author | Wang, Tongfei Li, Wei Li, Haitao Li, Weina |
author_facet | Wang, Tongfei Li, Wei Li, Haitao Li, Weina |
author_sort | Wang, Tongfei |
collection | PubMed |
description | Non-small cell lung cancer (NSCLC) is the main reason of cancer linked mortality and around 80% of cases diagnosed in advanced stage. Therefore current study designed to evaluate the deregulation of miRNA-194 and miRNA-192 in different body fluid of Non small cell lung cancer participants. Present study recruited newly diagnosed histopathologically confirmed. It was observed that the 40% NSCLC participants showed elevated miR-194 expression and 60% NSCLC participants showed reduced miR-194 expression in serum sample while in Bronchial wash, only 20% NSCLC participants showed elevated miR-194 expression while 80% showed reduced miR-194 expression (p = 0.003). It was found that the 54% NSCLC participants showed elevated miR-192 expression and 55% NSCLC participants showed reduced miR-192 expression in serum sample while In Bronchial wash sample, only 25% NSCLC participants showed high miR-192 expression while 75% showed low miR-192 expression (P = 0.0004). Expression of miR-194 was significantly associated with TNM stages (p < 0.0001, p < 0.0001), distant organ metastases (p < 0.0001, p < 0.0001), pathological grade (p = 0.0009, p = 0.0005) among serum sample and bronchial wash sample. Same observation was found with expression of miR-192 and it was significantly associated with TNM stages (p < 0.0001, p < 0.0001), distant organ metastases (p < 0.0001, p < 0.0001), pathological grade (p = 0.006, p = 0.001) among serum sample and bronchial wash sample. It was observed that the NSCLC participants who had high serum based miR-194 expression showed 22 months of overall median survival while low expression of serum based miR-194 expression showed 18 months of overall median survival. Present study suggests that decreased expression of miR-194 and miR-192 was significantly associated with different clinical features of NSCLC cases. However, significantly higher number of NSCLC cases showed low expression of miR-194 and miR-192 in bronchial lavage sample. Decreased poor overall survival was found to be associated with bronchial wash sample with respect to low miR-194 and miR-192 expression while NSCLC participants showed better overall survival with high miR-194 and miR-192 expression. This suggested decreased expression of miR-192 and miR-194 expression could be the potential prognostic marker among NSCLC participants. |
format | Online Article Text |
id | pubmed-7938118 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-79381182021-03-16 Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients Wang, Tongfei Li, Wei Li, Haitao Li, Weina Saudi J Biol Sci Original Article Non-small cell lung cancer (NSCLC) is the main reason of cancer linked mortality and around 80% of cases diagnosed in advanced stage. Therefore current study designed to evaluate the deregulation of miRNA-194 and miRNA-192 in different body fluid of Non small cell lung cancer participants. Present study recruited newly diagnosed histopathologically confirmed. It was observed that the 40% NSCLC participants showed elevated miR-194 expression and 60% NSCLC participants showed reduced miR-194 expression in serum sample while in Bronchial wash, only 20% NSCLC participants showed elevated miR-194 expression while 80% showed reduced miR-194 expression (p = 0.003). It was found that the 54% NSCLC participants showed elevated miR-192 expression and 55% NSCLC participants showed reduced miR-192 expression in serum sample while In Bronchial wash sample, only 25% NSCLC participants showed high miR-192 expression while 75% showed low miR-192 expression (P = 0.0004). Expression of miR-194 was significantly associated with TNM stages (p < 0.0001, p < 0.0001), distant organ metastases (p < 0.0001, p < 0.0001), pathological grade (p = 0.0009, p = 0.0005) among serum sample and bronchial wash sample. Same observation was found with expression of miR-192 and it was significantly associated with TNM stages (p < 0.0001, p < 0.0001), distant organ metastases (p < 0.0001, p < 0.0001), pathological grade (p = 0.006, p = 0.001) among serum sample and bronchial wash sample. It was observed that the NSCLC participants who had high serum based miR-194 expression showed 22 months of overall median survival while low expression of serum based miR-194 expression showed 18 months of overall median survival. Present study suggests that decreased expression of miR-194 and miR-192 was significantly associated with different clinical features of NSCLC cases. However, significantly higher number of NSCLC cases showed low expression of miR-194 and miR-192 in bronchial lavage sample. Decreased poor overall survival was found to be associated with bronchial wash sample with respect to low miR-194 and miR-192 expression while NSCLC participants showed better overall survival with high miR-194 and miR-192 expression. This suggested decreased expression of miR-192 and miR-194 expression could be the potential prognostic marker among NSCLC participants. Elsevier 2021-03 2021-01-20 /pmc/articles/PMC7938118/ /pubmed/33732041 http://dx.doi.org/10.1016/j.sjbs.2021.01.013 Text en © 2021 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Wang, Tongfei Li, Wei Li, Haitao Li, Weina Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients |
title | Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients |
title_full | Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients |
title_fullStr | Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients |
title_full_unstemmed | Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients |
title_short | Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients |
title_sort | dysregulation of exosomal mir-192 and mir-194 expression in lung adenocarcinoma patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938118/ https://www.ncbi.nlm.nih.gov/pubmed/33732041 http://dx.doi.org/10.1016/j.sjbs.2021.01.013 |
work_keys_str_mv | AT wangtongfei dysregulationofexosomalmir192andmir194expressioninlungadenocarcinomapatients AT liwei dysregulationofexosomalmir192andmir194expressioninlungadenocarcinomapatients AT lihaitao dysregulationofexosomalmir192andmir194expressioninlungadenocarcinomapatients AT liweina dysregulationofexosomalmir192andmir194expressioninlungadenocarcinomapatients |